Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript

HRMY earnings call for the period ending December 31, 2023.

Related Keywords

United States ,America ,Danielle Brill Raymond James ,Francois Brisebois ,David Amsellem Piper Sandler ,Graig Suvannavejh ,Raymond James ,Jeff Dierks ,Jeffrey Dayno ,David Amsellem ,Charles Duncan ,Jason Gerberry ,Jeff Dayno ,Luis Sanay ,Francois Brisebois Oppenheimer ,Charles Duncan Cantor Fitzgerald ,Kumar Budur ,Piper Sandler ,Danielle Brill ,Fadia Needham ,Sandip Kapadia ,Jeffrey Dierks ,Company Analyst ,Cantor Fitzgerald ,Needham Company ,Alkermes ,Harmony Biosciences ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Prader Willi Syndrome ,Daytime Sleepiness Scale ,Fatigue Severity Scale ,Ami Fadia ,Next Gen ,Fourth Quarter ,Chief Medical Officer ,Chief Executive Officer ,Market Opportunity ,Business Development ,Narcolepsy ,Clinical Development ,